All articles tagged with #cannabidiol
Preclinical study in a mouse model of Alzheimer's found inhaled cannabidiol (CBD) reduced key inflammatory pathways (IDO and cGAS), lowered proinflammatory cytokines, and improved recognition memory, suggesting CBD may exert a multitarget anti-inflammatory effect that could complement other approaches. However, results are early and in animals, and human studies are needed to assess safety and efficacy.
A scientific review suggests that CBD, a non-intoxicating compound in marijuana, shows significant potential as an anti-tumor agent across various cancers, including aggressive types like glioblastoma, by disrupting multiple cancer pathways. However, challenges such as poor absorption and delivery methods remain, and further clinical research is needed to confirm its efficacy in patients.
A study in mice suggests that cannabidiol (CBD) may improve memory and reduce brain plaques associated with Alzheimer's by calming overactive neurons through glycine receptors, highlighting its potential as a therapeutic option, though further research is needed.
Researchers at Indiana University have discovered a potential new method for reversing fentanyl overdoses by using modified cannabidiol (CBD) as a negative allosteric modulator at the opioid receptor binding site. Initial tests showed that modified CBD successfully reversed fentanyl effects in vitro, and further testing is planned to assess its ability to counteract respiratory depression, a primary overdose effect. This discovery could lead to a new way to reverse fentanyl overdoses, either through a new product or in conjunction with naloxone.
Researchers at Indiana University have discovered a new method to reverse the effects of fentanyl, a synthetic opioid that is significantly stronger than morphine. The study, published in the Journal of Medicinal Chemistry, suggests that cannabidiol (CBD) could act as a negative allosteric modulator at the binding site, effectively reversing the effects of fentanyl. Further testing is needed to determine if this method can reverse respiratory depression, the main overdose effect, in living organisms. This research could potentially lead to the development of a new product or a combination therapy with naloxone to combat fentanyl overdoses.